RAMO Ramoil Management, LTD. Announces an Agreemen
Post# of 72708
Posted On: 07/10/2014 8:55:42 AM
RAMO Ramoil Management, LTD. Announces an Agreement With Compliant Collective Consulting, LLC, Regarding RAMO Bio-Med, Inc. MacReport Media "Press Releases"
LAS VEGAS, NV , United States , via eTeligis Inc., 07/10/2014 - - RamoilM
anagement, LTD (OTC Pink: RAMO) (PINKSHEETS: RAMO), announces today that it has signed an agreement with Compliant Collective Consulting, LLC , for and on behalf of RAMO Bio-Med, Inc. to structure and develop the product lines, pro-marketing and pre-sales of said products under development and prior to market release in late August, 2014, by RAMO Bio-Med, Inc. , a Florida wholly owned subsidiary, as the operating entity of and for the "Supercritical CO2 Molecular Extraction" technology and facilities announced in the June 30 th, 2014 Press Release.
MichaelGoeree, the Company's Chairman, President and Chief Executive Officer, said: "I am proud to have retained a firm like Compliant Collective Consulting, LLC , with their extensive experience in the botanical concentrate market."
Mr.Goereefurther stated, "This will go a long way in growing sales and pre-booking revenues."
AboutRamoil Management, LTD.
Ramoil Management, LTD. (RAMO) is a development stage company. The Company is an online wholesaler of E-cigarettes containingnutraceuticalvapor oils, E-cigarette delivery systems and hydroponic lighting and nutrients.
About Compliant Collective Consulting, LLC .
Compliant Collective Consulting, LLC .isa California , Limited Liability Company in the business of consulting on the market, marketing and sales of botanical concentrates. Compliant Collective Consulting has been in business for 3+ years.
About RAMO Bio-Med, Inc.
RAMO Bio-Med, Inc. is a wholly owned subsidiary ofRamoil Management, LTD. (RAMO) and is a development stage company. The Company is the operating company of the newly acquired "Supercritical CO2 Molecular Extraction Technology" and will be building operating production facilities and research labs, both domestically and internationally.
Forward Looking Statements:
This news release contains forward-looking statements made by RAMOIL MANAGEMENT, LTD. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward-looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.
CONTACT:
Company and Investor Relations Contact:
FrankBlainey, Esq.
+1-702-381-1961
Ramoilir@gmail.com
SOURCE:Ramoil Management, LTD.
LAS VEGAS, NV , United States , via eTeligis Inc., 07/10/2014 - - RamoilM
anagement, LTD (OTC Pink: RAMO) (PINKSHEETS: RAMO), announces today that it has signed an agreement with Compliant Collective Consulting, LLC , for and on behalf of RAMO Bio-Med, Inc. to structure and develop the product lines, pro-marketing and pre-sales of said products under development and prior to market release in late August, 2014, by RAMO Bio-Med, Inc. , a Florida wholly owned subsidiary, as the operating entity of and for the "Supercritical CO2 Molecular Extraction" technology and facilities announced in the June 30 th, 2014 Press Release.
MichaelGoeree, the Company's Chairman, President and Chief Executive Officer, said: "I am proud to have retained a firm like Compliant Collective Consulting, LLC , with their extensive experience in the botanical concentrate market."
Mr.Goereefurther stated, "This will go a long way in growing sales and pre-booking revenues."
AboutRamoil Management, LTD.
Ramoil Management, LTD. (RAMO) is a development stage company. The Company is an online wholesaler of E-cigarettes containingnutraceuticalvapor oils, E-cigarette delivery systems and hydroponic lighting and nutrients.
About Compliant Collective Consulting, LLC .
Compliant Collective Consulting, LLC .isa California , Limited Liability Company in the business of consulting on the market, marketing and sales of botanical concentrates. Compliant Collective Consulting has been in business for 3+ years.
About RAMO Bio-Med, Inc.
RAMO Bio-Med, Inc. is a wholly owned subsidiary ofRamoil Management, LTD. (RAMO) and is a development stage company. The Company is the operating company of the newly acquired "Supercritical CO2 Molecular Extraction Technology" and will be building operating production facilities and research labs, both domestically and internationally.
Forward Looking Statements:
This news release contains forward-looking statements made by RAMOIL MANAGEMENT, LTD. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward-looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.
CONTACT:
Company and Investor Relations Contact:
FrankBlainey, Esq.
+1-702-381-1961
Ramoilir@gmail.com
SOURCE:Ramoil Management, LTD.
(0)
(0)Scroll down for more posts ▼